Federal Crackdown on Medicare and Medicaid Fraud Intensifies as Sixth Circuit Provides Compliance Roadmap

Federal and state authorities are significantly ramping up enforcement actions against healthcare fraud, using advanced technology to target providers who improperly bill Medicare and Medicaid programs that serve millions of Americans.

The Department of Justice has deployed sophisticated data analytics and artificial intelligence tools to identify suspicious billing patterns, leading to substantial results in recent operations. The 2025 National Health Care Fraud Takedown resulted in criminal charges against 324 defendants, including 96 licensed medical professionals, for schemes involving over $14.6 billion in intended losses.

Meanwhile, the Centers for Medicare and Medicaid Services (CMS) prevented more than $4 billion in improper payments and suspended or revoked billing privileges for 205 providers. Civil enforcement has been equally aggressive, with actions against more than 120 defendants resulting in tens of millions of dollars in settlements.

Recent decisions by the U.S. Court of Appeals for the Sixth Circuit reflect this intensified enforcement landscape, particularly targeting medically unnecessary services, inadequate documentation, and fraudulent billing practices. These cases provide valuable guidance for healthcare providers seeking to maintain compliance.

In United States v. Siefert, the court affirmed convictions related to an overbilling scheme involving unnecessary urine drug testing. Evidence revealed a deliberate practice of ordering high-reimbursement tests without patient-specific medical necessity. The court also upheld conspiracy convictions against a clinic operator, with both the clinic owner and medical director receiving prison sentences and substantial restitution orders.

Another significant case, United States v. Campbell, saw the Sixth Circuit affirm convictions of a physician and nurse practitioner for conspiracy to unlawfully distribute controlled substances, healthcare fraud, and money laundering. The fraud charges stemmed from billing for services at improperly high evaluation and management levels and misusing proceeds for staff bonuses. Evidence of drug distribution conspiracy included brief patient visits, pre-signed prescriptions, patients traveling long distances, and continued prescribing despite failed drug tests.

Civil enforcement under the False Claims Act remains a substantial risk through qui tam actions. In United States ex rel. Owsley v. Fazzi Associates, Inc., the Sixth Circuit affirmed dismissal of a case alleging upcoding of home-health assessment data submitted to Medicare. Despite allegations of a fraudulent scheme, the court held that the complaint failed to meet heightened pleading standards, as it didn’t identify representative claims or provide sufficient details such as dates, amounts, or claim identifiers.

Healthcare providers can take several practical steps to reduce both criminal and civil exposure. For medical necessity and documentation, conducting patient-specific assessments and clearly linking each service to current clinical needs is essential. Providers should avoid standardized testing or treatment policies lacking individualized justification.

Technology and timeliness concerns should be addressed by regularly validating equipment performance and suspending billing when delays or deficiencies undermine clinical value. For coding and billing, providers must match codes to services actually rendered and document elements required for each code while confirming payer- and program-specific billing rules before submission.

Compensation structures should incentivize compliance, quality, and patient outcomes rather than raw volume or high-risk services. Governance and audits should include independent, clinically grounded reviews with documented corrective actions, while taking staff compliance concerns seriously.

These enforcement trends highlight the critical importance of thorough documentation, proper billing practices, and robust compliance programs. As federal authorities continue to enhance their fraud detection capabilities, healthcare providers must remain vigilant in their compliance efforts to avoid potentially devastating legal consequences.